Ongoing Developments in Multiomics Driving the Global Multiomics Market

The global multiomics market is anticipated to grow at a considerable CAGR of 16.5% during the forecast period (2023-2031). The ongoing market development like mergers & acquisitions, partnerships, collaborations, funding, and product launches by key players such as Bio Rad Laboratories, Inc., Thermo Fischer Scientific Inc., Mission Bio, Inc., Danaher Corp., and Illumina among others is a contributor to the global market growth.

Browse the full report description of “Multiomics Market Size, Share & Trends Analysis Report by Product & Services (Product and Services), by Type (Single-cell Multiomics and Bulk Multiomics), by Application (Cell Biology, Oncology, Neurology, and Immunology), by End-User (Pharma & Biotech Companies, Academics & Research Organization, and Hospital & Diagnostic Laboratories), Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/multiomics-market

• In September 2023, the Keck School of Medicine of USC received funding from the National Institutes of Health as part of a five-year, $50.3 million “multi-omics” study of human health and disease involving six sites. Researchers in the Multi-Omics for Health and Disease consortium will study fatty liver disease, hepatocellular carcinoma, asthma, chronic kidney disease, preeclampsia, and other conditions, with a focus on underrepresented racial and ethnic groups.

• In April 2023, Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced that it has agreed with Fulgent Genetics, a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. In the same month, Biomodal, formerly known as Cambridge Epigenetix, launched its new duet multiomics solution. This solution exhibits the combinatorial power of genetic and epigenetic information from a single low-volume sample.

• In February 2023, BD introduced a single-cell multiomics platform, BD Rhapsody HT Xpress System, to support researchers in scientific discovery in various fields, including genetic disease research, immunology, and cancer and chronic disorder research.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Products & services

o By Application

o By Type

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- includes Bio Rad Laboratories, Inc., Thermo Fischer Scientific Inc., Mission Bio, Inc., Danaher Corp., and Illumina among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Multiomics Market Report Segment

By Products & Services

• Products

o Instruments

o Consumables

o Software

• Services

By Type

• Single-cell Multiomics
• Bulk Multiomics

By Application

• Cell Biology
• Oncology
• Neurology
• Immunology

By End-User

• Pharma & Biotech Companies
• Academics & Research Organization
• Hospital and Diagnostic Laboratories

Global Multiomics Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/multiomics-market